• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食加肌醇、α-乳白蛋白:恢复肥胖和代谢异常患者体重和代谢特征的成功组合。

Diet Plus Inositols, α-Lactalbumin and : The Successful Combo to Restore Body Weight and Metabolic Profile in Obese and Dysmetabolic Patients.

机构信息

Section of Medical Pathophysiology, Food Science and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Nutrients. 2023 Jul 14;15(14):3142. doi: 10.3390/nu15143142.

DOI:10.3390/nu15143142
PMID:37513560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10385591/
Abstract

The primary control of dysmetabolic patients is extremely challenging worldwide, with inadequate dietary habits and sporadic physical activity among the key risk factors for metabolic syndrome onset. Nowadays, there is no exclusive treatment for this condition, and considering that preventive measures usually fail, new therapeutic approaches need to be proposed and investigated. This present pilot study compared the effects of diet alone and in association with a combination of myo-inositol and d-chiro-inositol in their 40:1 ratio, α-lactalbumin, and on different metabolic parameters in obese dysmetabolic patients. To this purpose, 37 patients with BMI between 30 and 40 and fasting blood glucose between 100 and 125 mg/dL were divided into two groups: () the control group followed a hypocaloric Mediterranean diet, () while the study group was also supplemented with a daily dosage of two sachets, each one containing 1950 mg myo-inositol, 50 mg d-chiro-inositol, 50 mg α-lactalbumin, and 250 mg . After a 6-month treatment, all parameters improved in both groups. Nevertheless, the treated group experienced a greater improvement, especially concerning the variation from the baseline of HOMA index, triglycerides, BMI, body weight, and waist circumference. These findings support the supplementation with myo-inositol and d-chiro-inositol in the 40:1 ratio, α-lactalbumin, and as a therapeutical strategy to potentiate the beneficial effects induced via dietary programs in dysmetabolic patients.

摘要

代谢异常患者的主要控制在全球范围内极具挑战性,不良饮食习惯和零星的体育活动是代谢综合征发病的关键危险因素。目前,尚无针对这种情况的特效治疗方法,而且考虑到预防措施通常无效,需要提出和研究新的治疗方法。本初步研究比较了单独饮食以及饮食联合肌醇和手性肌醇以 40:1 的比例、α-乳白蛋白和 对肥胖代谢异常患者不同代谢参数的影响。为此,将 37 名 BMI 在 30 至 40 之间且空腹血糖在 100 至 125mg/dL 之间的患者分为两组:()对照组遵循低热量地中海饮食,()而研究组还每天补充两袋,每袋含有 1950mg 肌醇、50mg 手性肌醇、50mgα-乳白蛋白和 250mg 。经过 6 个月的治疗,两组的所有参数都有所改善。然而,治疗组的改善更为明显,特别是在 HOMA 指数、甘油三酯、BMI、体重和腰围的基线变化方面。这些发现支持补充肌醇和手性肌醇以 40:1 的比例、α-乳白蛋白和 作为一种治疗策略,以增强饮食方案对代谢异常患者的有益作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d4/10385591/b50aaeadb016/nutrients-15-03142-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d4/10385591/b50aaeadb016/nutrients-15-03142-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d4/10385591/b50aaeadb016/nutrients-15-03142-g001.jpg

相似文献

1
Diet Plus Inositols, α-Lactalbumin and : The Successful Combo to Restore Body Weight and Metabolic Profile in Obese and Dysmetabolic Patients.饮食加肌醇、α-乳白蛋白:恢复肥胖和代谢异常患者体重和代谢特征的成功组合。
Nutrients. 2023 Jul 14;15(14):3142. doi: 10.3390/nu15143142.
2
Combined Inositols, α-Lactalbumin, Gymnema Sylvestre and Zinc Improve the Lipid Metabolic Profile of Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial.联合使用肌醇、α-乳白蛋白、匙羹藤和锌可改善2型糖尿病患者的脂质代谢状况:一项随机临床试验。
J Clin Med. 2023 Dec 13;12(24):7650. doi: 10.3390/jcm12247650.
3
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.口服胰岛素增敏剂二甲双胍、噻唑烷二酮类、肌醇和小檗碱改善多囊卵巢综合征女性内分泌和代谢谱的疗效比较:网络荟萃分析。
Reprod Health. 2021 Aug 18;18(1):171. doi: 10.1186/s12978-021-01207-7.
4
The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.联合治疗肌醇加 D-手性肌醇,按生理比例,通过改善多囊卵巢综合征患者的血脂谱降低心血管风险。
Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):537-40.
5
A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.一项多中心临床研究,研究对象为墨西哥和意大利的多囊卵巢综合征患者,研究药物为肌醇和乳白蛋白。
Eur Rev Med Pharmacol Sci. 2021 Apr;25(8):3316-3324. doi: 10.26355/eurrev_202104_25743.
6
Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome.比较肌醇加α-乳白蛋白与单独使用肌醇对多囊卵巢综合征生殖和代谢紊乱的疗效。
Metabolites. 2023 May 31;13(6):717. doi: 10.3390/metabo13060717.
7
Safety of inositol supplementation in patients taking lithium or valproic acid: a pilot clinical study.在服用锂或丙戊酸的患者中补充肌醇的安全性:一项初步临床研究。
Eur Rev Med Pharmacol Sci. 2022 Oct;26(19):7269-7276. doi: 10.26355/eurrev_202210_29920.
8
Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study.多囊卵巢综合征患者联合使用肌醇、D-手性肌醇和葡甘露聚糖治疗后的代谢组学变化:一项初步研究。
J Ovarian Res. 2019 Mar 23;12(1):25. doi: 10.1186/s13048-019-0500-x.
9
Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.用 D-手性肌醇和α-硫辛酸治疗多囊卵巢综合征。
Gynecol Endocrinol. 2019 Jun;35(6):506-510. doi: 10.1080/09513590.2018.1540573. Epub 2019 Jan 7.
10
Enhancement of D-chiro-inositol transport across intestinal cells by alpha-Lactalbumin peptides.α-乳白蛋白肽增强肠道细胞对 D-手性肌醇的转运。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10143-10154. doi: 10.26355/eurrev_202010_23234.

引用本文的文献

1
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora's box.用高剂量D-手性肌醇治疗胰岛素抵抗肥胖女性的意外效果:打开潘多拉魔盒。
Front Endocrinol (Lausanne). 2025 Apr 1;16:1399308. doi: 10.3389/fendo.2025.1399308. eCollection 2025.
2
Cordycepin Ameliorates High Fat Diet-Induced Obesity by Modulating Endogenous Metabolism and Gut Microbiota Dysbiosis.虫草素通过调节内源性代谢和肠道微生物失调改善高脂肪饮食诱导的肥胖。
Nutrients. 2024 Aug 27;16(17):2859. doi: 10.3390/nu16172859.
3
Comparative Effects of and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study.

本文引用的文献

1
D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2).D-手性肌醇和肌醇诱导两种不同的人脂肪细胞模型(SGBS 和 LiSa-2)的白色脂肪/棕色脂肪转分化。
Int J Mol Sci. 2023 Apr 18;24(8):7421. doi: 10.3390/ijms24087421.
2
A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?多囊卵巢综合征的矛盾现象:肌醇治疗是否适用于所有不同表型?
Int J Mol Sci. 2023 Mar 25;24(7):6213. doi: 10.3390/ijms24076213.
3
Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
和小檗碱对肥胖患者脂联素、体成分和代谢参数的比较影响:一项随机研究。
Nutrients. 2024 Jul 16;16(14):2284. doi: 10.3390/nu16142284.
4
Milk Bioactive Compounds and Gut Microbiota Modulation: The Role of Whey Proteins and Milk Oligosaccharides.牛奶生物活性成分与肠道微生物群调节:乳清蛋白和牛奶寡糖的作用
Foods. 2024 Mar 16;13(6):907. doi: 10.3390/foods13060907.
5
<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).《临床实践中的 D-手性肌醇:基础与临床研究手性肌醇专家组(EGOI)的观点》。
Gynecol Obstet Invest. 2024;89(4):284-294. doi: 10.1159/000536081. Epub 2024 Feb 19.
6
Combined Inositols, α-Lactalbumin, Gymnema Sylvestre and Zinc Improve the Lipid Metabolic Profile of Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial.联合使用肌醇、α-乳白蛋白、匙羹藤和锌可改善2型糖尿病患者的脂质代谢状况:一项随机临床试验。
J Clin Med. 2023 Dec 13;12(24):7650. doi: 10.3390/jcm12247650.
肌醇是多囊卵巢综合征的一种有效且安全的治疗方法:一项随机对照试验的系统评价和荟萃分析。
Reprod Biol Endocrinol. 2023 Jan 26;21(1):10. doi: 10.1186/s12958-023-01055-z.
4
Positive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome.α-乳白蛋白对多囊卵巢综合征症状管理的积极影响。
Nutrients. 2022 Aug 6;14(15):3220. doi: 10.3390/nu14153220.
5
Determinants of adherence to diet and exercise behaviours among individuals with metabolic syndrome based on the Capability, Opportunity, Motivation, and Behaviour model: a cross-sectional study.基于能力-机会-动机-行为模型的代谢综合征患者饮食和运动行为依从性的决定因素:一项横断面研究。
Eur J Cardiovasc Nurs. 2023 Mar 1;22(2):193-200. doi: 10.1093/eurjcn/zvac034.
6
Inositol supplementation and body mass index: A systematic review and meta-analysis of randomized clinical trials.肌醇补充剂与体重指数:随机临床试验的系统评价和荟萃分析
Obes Sci Pract. 2021 Oct 22;8(3):387-397. doi: 10.1002/osp4.569. eCollection 2022 Jun.
7
Inositols: From Established Knowledge to Novel Approaches.肌醇:从已有知识到新方法。
Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575.
8
The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis.武靴藤补充剂对 2 型糖尿病患者血糖控制的影响:系统评价和荟萃分析。
Phytother Res. 2021 Dec;35(12):6802-6812. doi: 10.1002/ptr.7265. Epub 2021 Sep 1.
9
Inositols Depletion and Resistance: Principal Mechanisms and Therapeutic Strategies.肌醇耗竭与耐药:主要机制与治疗策略。
Int J Mol Sci. 2021 Jun 24;22(13):6796. doi: 10.3390/ijms22136796.
10
A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.一项多中心临床研究,研究对象为墨西哥和意大利的多囊卵巢综合征患者,研究药物为肌醇和乳白蛋白。
Eur Rev Med Pharmacol Sci. 2021 Apr;25(8):3316-3324. doi: 10.26355/eurrev_202104_25743.